Advertisement

Topics

Search Results for "Sangart Pharma"

04:46 EDT 3rd May 2016 | BioPortfolio

Matching Channels

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...

Laboratory

Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...

OxyContin

OxyContin, an narcotic <!--LGfEGNT2Lhm-->analgesic produced by Purdue Pharma LP, nets $3m in <!--LGfEGNT2Lhm-->sales annually, placing it 8th in the world for annual sales. OxyContin i...

Eligard

Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...

Zyme Communications

Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value, and generate interest from commercial leads...

Matching News

Forenap Pharma E.U.R.L. - Strategic SWOT Analysis Review

Recently added to the BioPortfolio report store, Forenap Pharma E.U.R.L. - Strategic SWOT Analysis Review is a new report from GlobalData published on 2015-09-11. This 15-page report is available in ...

BRIEF-UK's CMA says not to refer Leo Pharma deal to buy Astellas Pharma portfolio to investigation

* Decided not to refer anticipated acquisition by Leo Pharma of the portfolio of pharma dermatological products of Astellas Pharma to phase 2 investigation Source text for Eikon: Further company cover...

Bal Pharma Limited (BALPHARMA) - Financial and Strategic SWOT Analysis Review

Recently added to the BioPortfolio report store, Bal Pharma Limited (BALPHARMA) - Financial and Strategic SWOT Analysis Review is a new report from GlobalData published on 2015-09-11. This 25-page re...

New York Pharma Forum explores ‘The Reinvention of Pharma’

David SalazarThe New York Pharma Forum’s 26th annual General Assembly featured a panel discussion and presentations from several experts in the global pharma industry. read more

Moberg Pharma Divests Three Brands for $10.0 Million

Regulatory News: Moberg Pharma (STO:MOB) Moberg Pharma AB (OMX: MOB) announces that the company has entered into an agreement with Strides Pharma Inc. to divest the brands Jointflex, Fergon and Va...

B.M.P. Pharma Trading AG (BMP) - Financial and Strategic SWOT Analysis Review

Recently added to the BioPortfolio report store, B.M.P. Pharma Trading AG (BMP) - Financial and Strategic SWOT Analysis Review is a new report from GlobalData published on 2015-09-11. This 25-page re...

Celtic Pharma: Attracting Big Pharma with experience and raising US$ 750M

In this interview, filmed at PharmaTelevision’s Oxford Studios, Dr Fintan Walton speaks with Stephen Parker, Partner at Celtic Pharma, a source of private equity and venture capital created in 2004....

IRW-News: Veritas Pharma Inc.: Veritas Pharma Inc.: Privatplatzierungsangebot

IRW-PRESS: Veritas Pharma Inc.: Veritas Pharma Inc.: Privatplatzierungsangebot PRIVATPLATZIERUNGSANGEBOT Vancouver (British Columbia), 8. März 2016. Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; Fran...

Matching PubMed Articles

Digital health revolution: Perfect storm or perfect opportunity for pharmaceutical R&D?

The convergence of technology and medicine has pushed healthcare to the brink of a major disruption that pharma has, until recently, been slow to recognize. Tech players have pioneered the emerging fi...

Pharma Success in Product Development-Does Biotechnology Change the Paradigm in Product Development and Attrition.

The biotechnology segment of the overall biopharma industry has existed for only about 40-45 years, as a driver of new product development. This driving force was initiated with the FDA approval of r...

Management of osteoarthritis (OA) with the pharma-standard supplement FlexiQule (Boswellia): a 12-week registry.

This registry study assessed the pharma-standard supplement FlexiQule (Boswellia extract in capsules) in the management of symptoms associated to osteoarthritis (OA) also managed with the 'standard ma...

Pharma Exposure Occurs Early in Training and More Often in Rural Clinical Sites.

Starting up and spinning out: The changing nature of partnerships between pharma and academia.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement